1. Home
  2. ADAG vs BGIN Comparison

ADAG vs BGIN Comparison

Compare ADAG & BGIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$2.80

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$2.45

Market Cap

237.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ADAG
BGIN
Founded
2011
2019
Country
China
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.2M
237.6M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
ADAG
BGIN
Price
$2.80
$2.45
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $9.91
N/A
AVG Volume (30 Days)
★ 277.3K
17.6K
Earning Date
08-12-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$129.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$1.61
52 Week High
$4.85
$5.19

Technical Indicators

Market Signals
Indicator
ADAG
BGIN
Relative Strength Index (RSI) 34.86 68.52
Support Level $2.80 $2.43
Resistance Level $3.19 $2.99
Average True Range (ATR) 0.29 0.16
MACD -0.01 0.07
Stochastic Oscillator 16.77 89.57

Price Performance

Historical Comparison
ADAG
BGIN

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is a digital asset technology company engaged in cryptocurrency mining technologies, self-mining operations, and the design and sale of ASIC mining machines. The company develops proprietary mining hardware under its ICERIVER brand and provides mining infrastructure and hosting solutions. It operates through two reportable segments: cryptocurrency mining and sale of mining machines. The company focuses on cryptocurrencies such as Bitcoin, Dogecoin, KAS, ALPH, and RXD. Geographically, it derives revenue from Hong Kong, China, Vietnam, the United States, Singapore, and other markets.

Share on Social Networks: